Jump to content

GcMAF treatment for cancer suppressed by government


Recommended Posts

Dr. Yamamoto successfully sold his patents for GcMAF and related IP to an Israeli bio company, Efranat, in '09. The company raised money [1] based on data in dogs with cancer [2] and started a PhI human trial [3]. However, they weren't able to secure additional funding and went out of business.


David Noakes' Immuno Biotech company claimed producing it, but was raided by the MHRA [4].







Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...